• 제목/요약/키워드: Gamma Knife radiosurgery

검색결과 128건 처리시간 0.03초

Prognostic Factors and Scoring Systems for Non-Small Cell Lung Cancer Patients Harboring Brain Metastases Treated with Gamma Knife Radiosurgery

  • Eom, Jung-Seop;Cho, Eun-Jung;Baek, Dong-Hoon;Lee, Kyung-Nam;Shin, Kyung-Hwa;Kim, Mi-Hyun;Lee, Kwang-Ha;Kim, Ki-Uk;Park, Hye-Kyung;Kim, Yun-Sung;Park, Soon-Kew;Cha, Seong-Heon;Lee, Min-Ki
    • Tuberculosis and Respiratory Diseases
    • /
    • 제72권1호
    • /
    • pp.15-23
    • /
    • 2012
  • Background: The survival of non-small cell lung cancer (NSCLC) patients with brain metastases is reported to be 3~6 months even with aggressive treatment. Some patients have very short survival after aggressive treatment and reliable prognostic scoring systems for patients with cancer have a strong correlation with outcome, often supporting decision making and treatment recommendations. Methods: A total of one hundred twenty two NSCLC patients with brain metastases who received gamma knife radiosurgery (GKRS) were analyzed. Survival analysis was calculated in all patients for thirteen available prognostic factors and four prognostic scoring systems: score index for radiosurgery (SIR), recursive partitioning analysis (RPA), graded prognostic assessment (GPA), and basic score for brain metastases (BSBM). Results: Age, Karnofsky performance status, largest brain lesion volume, systemic chemotherapy, primary tumor control, and medication of epidermal growth factor receptor tyrosine kinase inhibitor were statistically independent prognostic factors for survival. A multivariate model of SIR and RPA identified significant differences between each group of scores. We found that three-tiered indices such as SIR and RPA are more useful than four-tiered scoring systems (GPA and BSBM). Conclusion: There is little value of RPA class III (most unfavorable group) for the same results of 6-month and 1-year survival rate. Thus, SIR is the most useful index to sort out patients with poorer prognosis. Further prospective trials should be performed to develop a new molecular- and gene-based prognostic index model.

송과선 및 이소성 송과선 생식세포종의 감마 나이프 수술 후 재발 양상 (Failure Pattern of Pineal and Ectopic Pineal Germ Cell Tumor after Gamma Knife Radiosurgery)

  • 조흥래;손승창
    • Radiation Oncology Journal
    • /
    • 제18권2호
    • /
    • pp.92-100
    • /
    • 2000
  • 목적 :본 연구의 목적은 뇌 생식 세포종 환자들의 방사선치료 시 가장 적절한 조사 영역을 알아보고자 시행하였다. 대상 및 방법 : 1993년부터 1998년까지 뇌 생식세포종으로 진단되거나 또는 추정되어 감마 나이프를 시행 받은 환자 19 명을 대상으로 분석하였다. 송과선 9예, 안상(suprasellar) 1예, 그 외 2군데 이상 다발성 병소가 9예였다. 조직이 확인이 된 예는 7예이었고 배아종(germ ceil tumor)이 5명, 내배엽동종(endodermal sinus tumor)이 2명이었다. 종양의 부피는 2.4 cm$^{3}$부터 74 cm$^{3}$ 까지 이었다. 감마나이프 방사선 치료는 50% 등선량 곡선을 중심으로 10 Gy부터 20 Gy에 걸쳐 조사되었다. 추적 기간은 10개월에서부터 54개월까지였다. 결과 : 총 19명 중 14명(74%)에서 재발을 하였다. 완전 관해와 부분 관해는 각각 2명(11%), 10명(53%)이었다. 무반응은 7명(36%)이었다. 원발 병소가 있었던 자리에서 재발한 경우가 2예, 치료 조사영역을 벗어났으나 원발 병소와 연결되어서 그 주위로 재발한 경우가 6예 이었다. 원발 병소와 떨어져서 뇌실 재발이 된 경우 3예, 척수 전이가 된 경우가 4예 이었다. 종양의 부피가 20 cm$^{3}$ 이하인 경우는 8예이었으며 이중 2예는 치료 조사영역 내에서만 재발한 경우, 4예는 원발 병소와 연이어져서 치료 부위 주위로 재발한 경우, 1예는 척수 전이된 경우이었다. 종양의 부피가 20 cm$^{3}$ 보다 큰 경우는 6예 이었으며 그 중 원발 병소와 연이어져서 치료 부위 주위에 재발한 경우 1예, 원발 병소와 떨어져서 뇌실 전이가 된 경우가 2예, 척수 전이를 일으킨 경우가 3예였다. 재발을 하지 않은 5예는 종양의 부피가 20 cm$^{3}$ 이하인 경우이고 모두 단일 병소이며 종양기표가 모두 정상이었다. 척수 전이는 4예(21%)에서 발생하였으며 모두 뇌실 침범이 있는 경우에 발생하였다. 총 9명의 다발성 병소 중 국소 재발만을 한 경우는 3경우이었고 나머지는 모두 치료 조사영역을 벗어나 원발 병소와 떨어져서 재발하였다. 결론 : 감마 나이프 치료가 뇌 생식세포종에 대한 치료로서는 부적절한 치료이며 이것은 감마 나이프의 특성인 작은 치료 용적과 조사 선량의 부적절함에서 기인하는 것으로 판단된다. 뇌 생식 세포종에서 병소 부위 만을 치료하는 경은 종양의 부피와 다발성 병소의 뇌실 침범 유무가 치료 성공의 열쇠이다. 20 cm$^{3}$ 이하, 단일 병소, 뇌실 침범이 혀는 경우, 정상적인 종양지표, 등이 가장 이상적인 적응증이 될 수 있다. 다발성 병소에서 뇌실 침범이나 뇌실 병소가 있을 경우는 예방적 뇌 척수 조사를 고려해야 할 것으로 생각된다. 병소의 크기가 cm$^{3}$ 보다 클 경우 다발성 병소인 경우, 종양지표의 증가가 있는 경우에는 확정적인 제안을 하기는 어렵지만 전 뇌실 조사 또는 부분방사선 조사가 시도될 수 있을 것으로 생각되며 이 경우가 선행 화학 요법과 함께 치료할 수 있는 대상이며, 앞으로 이 부분에 대한 연구가 계속 이루어질 것으로 생각된다.

  • PDF

Quantitative Feasibility Evaluation of 11C-Methionine Positron Emission Tomography Images in Gamma Knife Radiosurgery : Phantom-Based Study and Clinical Application

  • Lim, Sa-Hoe;Jung, Tae-Young;Jung, Shin;Kim, In-Young;Moon, Kyung-Sub;Kwon, Seong-Young;Jang, Woo-Youl
    • Journal of Korean Neurosurgical Society
    • /
    • 제62권4호
    • /
    • pp.476-486
    • /
    • 2019
  • Objective : The functional information of $^{11}C$-methionine positron emission tomography (MET-PET) images can be applied for Gamma knife radiosurgery (GKR) and its image quality may affect defining the tumor. This study conducted the phantom-based evaluation for geometric accuracy and functional characteristic of diagnostic MET-PET image co-registered with stereotactic image in Leksell $GammaPlan^{(R)}$ (LGP) and also investigated clinical application of these images in metastatic brain tumors. Methods : Two types of cylindrical acrylic phantoms fabricated in-house were used for this study : the phantom with an array-shaped axial rod insert and the phantom with different sized tube indicators. The phantoms were mounted on the stereotactic frame and scanned using computed tomography (CT), magnetic resonance imaging (MRI), and PET system. Three-dimensional coordinate values on co-registered MET-PET images were compared with those on stereotactic CT image in LGP. MET uptake values of different sized indicators inside phantom were evaluated. We also evaluated the CT and MRI co-registered stereotactic MET-PET images with MR-enhancing volume and PET-metabolic tumor volume (MTV) in 14 metastatic brain tumors. Results : Imaging distortion of MET-PET was maintained stable at less than approximately 3% on mean value. There was no statistical difference in the geometric accuracy according to co-registered reference stereotactic images. In functional characteristic study for MET-PET image, the indicator on the lateral side of the phantom exhibited higher uptake than that on the medial side. This effect decreased as the size of the object increased. In 14 metastatic tumors, the median matching percentage between MR-enhancing volume and PET-MTV was 36.8% on PET/MR fusion images and 39.9% on PET/CT fusion images. Conclusion : The geometric accuracy of the diagnostic MET-PET co-registered with stereotactic MR in LGP is acceptable on phantom-based study. However, the MET-PET images could the limitations in providing exact stereotactic information in clinical study.

해면상 혈관종의 자연 경과와 치료 전략 (Cavernous Angioma : Natural History and Management Strategies)

  • 임효주;권양;안재성;김정훈;김창진;이정교;권병덕
    • Journal of Korean Neurosurgical Society
    • /
    • 제29권8호
    • /
    • pp.1001-1007
    • /
    • 2000
  • Objective : We analysed diverse clinical features of the cavernous angioma. Also, we report the experience in differ-ent methods of the management and their results. Method : Data from 80 patients who were confirmed pathologically or diagnosed radiologically between Jan. 1990 and Sept. 1998 at our hospital were analysed. Variable factors that were examined were : clinical features, effects of treatment, and complications. Results : There were 47 male and 33 female patients. The age at the first presentation was from 3 to 57(mean 34.1) years old. Clinical features were seizure in 28 cases(38%), bleeding in 24 cases(32%), neurologic deficits in 12 cases(16%), headache in 10 cases(14%), and six incidental cases. The locations of lesion were cerebral and cerebellar hemisphere in 45 cases(56.2%), brainstem, basal ganglia, and thalamus in 32 cases(40%), multiple in 3 cases (3.8%). Seizure was common at the third decade and occurred frequently with the cavernous angioma in temporal (43%) or frontal lobe(39%). Bleeding was frequent after the third decade with peak at the fourth decade and had high incidence in brainstem or thalamus. The gamma-knife radiosurgery was done in 47 cases. Rebleeding occurred in 3 cases, but it was within postradiosurgery 1 year. Symptomatic radiation change occurred in 2 cases of 8 radiation change on MRI. On follow-up MRI, no evidence of rebleeding was found in 30 cases. Also, The lesion size was decreased in 3 cases. Resection was performed in 23 cases ; total 20, subtotal 2, partial 1. Postoperative complication occurred in 6 cases(26.1%). After surgery, 7(63.6%) of 11 seizure patients had outcome of seizure-free. Subclinical rebleeding occurred in one of two subtotal resected cases. In 11 patients, conservative management was done. There was neither rebleeding nor symptom aggravation during follow-up period of mean 17.2 months. Conclusion : The solution for prevention of rebleeding is complete removal of the lesion located at noneloquent area or accessible region, especially for the patients who presented symptoms or intractable seizure. However, the Gamma knife radiosurgery is considered when the lesions are located at eloquent area or when severe postoperative morbidity is expected.

  • PDF

다양한 Plugging 형태를 이용한 감마나이프의 선택적 빔 차폐 방법 (Selective Beam Shielding Method of Gamma-Knife Unit Using Various Plugging Patterns)

  • 장건호;임영진;신동오;최두호;홍성언;임언
    • Radiation Oncology Journal
    • /
    • 제11권2호
    • /
    • pp.439-448
    • /
    • 1993
  • Leksell 감마나이프(B-형)가 1992년 3월 경희대학교 의과대학 병원에 설치되었다. 선택적 빔 Plugging방법을 이용하여 정상 민감 조직에 대한 저선량 분포를 현저히 줄일 수 있으며, 또한 치료 부위에 더 좋은 선량 분포를 얻을 수 있다. 저선량에 대한 여러가지 선량 분포의 변화에 대한 연구를 하였으며, 사용중인 KULA프로그램의 선량 분포 곡선을 평가하기 위해 필름을 이용한 방사선량 계측을 실시하였고, RFA-3자동 밀도 측정기를 이용하여 평가하였다. 1992년 3월부터 1993년 2월까지 1년동안 100명의 환자중 17명의 환자에 선택적 빔 차폐 방법이 적용되었다. 고선량 영역에서는 측정값과 프로그램에서 제공된 선량 분포가 잘 일치하였다. 뇌하수체 선종의 치료시 치료 부위가 클 경우에는 본 연구 방법의 적용이 매우 중요시 되었으며, 반면에 치료 영역이 작을 경우에는 적절한 헬맷의 선택이 중요함을 알 수 있었다. 치료 환자의 중요 민감 장기의 방사선 선량 평가에서는 뇌간에 3~12 Gy, 시신경 교차에 3~11.2 Gy이었다. 중추신경계 영역의 최적화된 치료를 위하여 다양한 Plugging형태를 임상에 적용하는 것이 방사선에 민감한 정상 조직을 보호하기 위해 매우 중요한 인자가 됨을 알았다.

  • PDF

The Role of Radiosurgery in Patients with Brain Metastasis from Small Cell Lung Carcinoma

  • Jo, Kwang-Wook;Kong, Doo-Sik;Lim, Do-Hoon;Ahn, Yong-Chan;Nam, Do-Hyun;Lee, Jung-Il
    • Journal of Korean Neurosurgical Society
    • /
    • 제50권2호
    • /
    • pp.99-102
    • /
    • 2011
  • Objective : The purpose of this retrospective study was to evaluate the outcome of gamma knife radiosurgery (GKRS) and/or whole brain radiation therapy (WBRT) for the treatment of small cell lung carcinoma (SCLC) metastasis to the brain. Methods : From 2000 to 2010, 50 patients underwent GKRS for metastatic brain lesions originating from SCLC. Among these patients, 11 received prophylactic cranial irradiation (PCI) before the development of metastatic lesions (PCI group), and GKRS was performed as an initial treatment for newly diagnosed lesions in 12 patients who had not received PCI (primary GKRS group). In addition, GKRS was performed as a salvage treatment for progressive lesions after WBRT in 27 patients (salvage GKRS group). The medical records and imaging data of all patients were retrospectively analyzed. Results : The overall survival of the 50 patients was 20.8 months (range 1-53) after the diagnosis of primary tumor and 12.0 months (range 1-47) after the development of cerebral metastasis. Median survival after GKRS was 4.8 months (range 1-15) in the PCI group, 4.6 months (range 0-18) in the primary GKRS group, and 7.6 months (range 0-33) in the salvage GKRS group. Further treatment for progressive lesions after GKRS was necessary in 15 patients, after a mean interval of 3.8 months. Causes of death were systemic organ failure in 15 patients, deterioration of neurological state in 13 patients, and unknown or combined causes in 16 patients. The local control rate of the lesions treated with GKRS was 76.4% (decreased in 13 patients and stable in 16 patients at the final imaging follow-up (mean 5.60 months). Conclusion : GKRS is an effective local treatment for brain metastasis from SCLC both as an initial treatment for newly diagnosed lesions after PCI and as a salvage treatment for recurrent or progressive lesions. However, the survival benefit is not significant because most patients die of systemic multi-organ failure with a short life expectancy.

선형 가속기를 이용한 정위적 방사선 수술시 병소내 선량분포의 특성조사 (Search of Characteristic for Dose Distribution Presented by Multi­isocentric Stereotactic Radiosurgical Plan Using Linear Accelerator)

  • 최경식;오승종;이형구;최보영;전흥재;서태석
    • 한국의학물리학회지:의학물리
    • /
    • 제14권4호
    • /
    • pp.225-233
    • /
    • 2003
  • 방사선 치료 계획의 목적은 정상 조직 부근에서는 최소한의 방사선 조사가 되는 동안 병소에는 동일한 선량이 조사되는 것이다. 선형가속기를 이용한 정위적 방사선 수술시 단일한 구형의 선량분포는 병소에 대하여 균등한 선량분포를 이루고, 병소 내에는 70% 이상의 고선량이 등선량 곡선내에 포함되면서 주위 정상조직에서는 급격히 낮은 선량을 가지게 한다. 또한 이와 같은 방법은 감마나이프를 이용한 정위적 방사선 수술의 경우와 비슷한 치료 계획을 나타낸다. 이처럼 정위적 방사선 수술시 이용되는 구형의 선량분포를 가지는 isocenter는 실제 방사선 수술 계획시 많은 시간과 경험을 바탕으로 수술 계획자에 의해 병소 내에 배치되어 진다. 본 연구는 효율적인 방사선 수술이 수행되도록 수술 계획시 구형 선량분포에 관여하는 빔관련 변수들을 고려하여 병소내 선량분포의 특성을 조사하였다. 이를 위해 불규칙한 형태의 병소를 직육면체형과 원통형으로 가정하여 비교하였고, 동일한 체적의 병소 모델에 대하여 빔관련 변수를 변화시켜 구형 선량분포를 이루는 isocenter들의 위치 및 콜리메이터의 크기를 달리하면서 병소 모델에 대한 선량 분포를 얻었다. 이때, 얻어진 선량분포 Dose Profile과 Dose Volume Histogram (DVH)으로 비교한 결과, 불규칙한 모양의 병소에 대하여 콜리메이터의 크기와 Isocenter의 개수, Isocenter의 간격 등의 빔관련 변수를 최적화함으로서 더 나은 고선량의 등선량 곡선(Isodose Curve)내에 병소를 포함시킬 수 있었다. 이러한 병소내 구형 선량 분포를 가지는 isocenter의 배치에 따른 특성들은 정위적 방사선 수술 계획시 더 효율적이면서, 빠른 수술 계획을 수립하는데 많은 도움이 될 것으로 사료된다.

  • PDF

The Influence of Biomarker Mutations and Systemic Treatment on Cerebral Metastases from NSCLC Treated with Radiosurgery

  • Lee, Min Ho;Kong, Doo-Sik;Seol, Ho Jun;Nam, Do-Hyun;Lee, Jung-Il
    • Journal of Korean Neurosurgical Society
    • /
    • 제60권1호
    • /
    • pp.21-29
    • /
    • 2017
  • Objective : The purpose of this study was to analyze outcomes and identify prognostic factors in patients with cerebral metastases from non-small cell lung cancer (NSCLC) treated with gamma knife radiosurgery (GKS) particularly, focusing on associations of biomarkers and systemic treatments. Methods : We retrospectively reviewed the medical records of 134 patients who underwent GKS for brain metastases due to NSCLC between January 2002 and December 2012. Representative biomarkers including epidermal growth factor receptor (EGFR) mutation, K-ras mutation, and anaplastic lymphoma kinase (ALK) mutation status were investigated. Results : The median overall survival after GKS was 22.0 months (95% confidence interval [CI], 8.8-35.1 months). During follow-up, 63 patients underwent salvage treatment after GKS. The median salvage treatment-free survival was 7.9 months (95% CI, 5.2-10.6 months). Multivariate analysis revealed that lower recursive partition analysis (RPA) class, small number of brain lesions, EGFR mutation (+), and ALK mutation (+) were independent positive prognostic factors associated with longer overall survival. Patients who received target agents 30 days after GKS experienced significant improvements in overall survival and salvage treatment-free survival than patients who never received target agents and patients who received target agents before GKS or within 30 days (median overall survival: 5.0 months vs. 18.2 months, and 48.0 months with p-value=0.026; median salvage treatment-free survival: 4.3 months vs. 6.1 months and 16.6 months with p-value=0.006, respectively). To assess the influence of target agents on the pattern of progression, cases that showed local recurrence and new lesion formation were analyzed according to target agents, but no significant effects were identified. Conclusion : The prognosis of patients with brain metastases of NSCLC after GKS significantly differed according to specific biomarkers (EGFR and ALK mutations). Our results show that target agents combined with GKS was related to significantly longer overall survival, and salvage treatment-free survival. However, target agents were not specifically associated with improved local control of the lesion treated by GKS either development of new lesions. Therefore, it seems that currently popular target agents do not affect brain lesions themselves, and can prolong survival by controlling systemic disease status.

Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery

  • Lee, Min Ho;Cho, Kyung-Rae;Choi, Jung Won;Kong, Doo-Sik;Seol, Ho Jun;Nam, Do-Hyun;Jung, Hyun Ae;Sun, Jong-Mu;Lee, Se-Hoon;Ahn, Jin Seok;Ahn, Myung-Ju;Park, Keunchil;Lee, Jung-Il
    • Journal of Korean Neurosurgical Society
    • /
    • 제64권2호
    • /
    • pp.271-281
    • /
    • 2021
  • Objective : Immune checkpoint inhibitors (ICIs) are approved for treating non-small-cell lung cancer (NSCLC); however, the safety and efficacy of combined ICI and Gamma Knife radiosurgery (GKS) treatment remain undefined. In this study, we retrospectively analyzed patients treated with ICIs with or without GKS at our institute to manage patients with brain metastases from NSCLC. Methods : We retrospectively reviewed medical records of patients with brain metastases from NSCLC treated with ICIs between January 2015 and December 2017. Of 134 patients, 77 were assessable for brain responses and categorized into three groups as follows : group A, ICI alone (n=26); group B, ICI with concurrent GKS within 14 days (n=24); and group C, ICI with non-concurrent GKS (n=27). Results : The median follow-up duration after brain metastasis diagnosis was 19.1 months (range, 1-77). At the last follow-up, 53 patients (68.8%) died, 20 were alive, and four were lost to follow-up. The estimated median overall survival (OS) of all patients from the date of brain metastasis diagnosis was 20.0 months (95% confidence interval, 12.5-27.7) (10.0, 22.5, and 42.1 months in groups A, B, and C, respectively). The OS was shorter in group A than in group C (p=0.001). The intracranial disease progression-free survival (p=0.569), local progression-free survival (p=0.457), and complication rates did not significantly differ among the groups. Twelve patients showed leptomeningeal seeding (LMS) during follow-up. The 1-year LMS-free rate in treated with ICI alone group (69.1%) was significantly lower than that in treated with GKS before ICI treatment or within 14 days group (93.2%) (p=0.004). Conclusion : GKS with ICI showed no favorable OS outcome in treating brain metastasis from NSCLC. However, GKS with ICI did not increase the risk of complications. Furthermore, compared with ICI alone, GKS with ICI may be associated with a reduced incidence of LMS. Further understanding of the mechanism, which remains unknown, may help improve the quality of life of patients with brain metastasis.

로봇 사이버나이프에서 위치인식시스템을 이용한 Targeting Error값 보정의 정확성 평가 (Evaluation on the Accuracy of Targeting Error Correction Through the Application of Target Locating System in Robotic CyberKnife)

  • 정영준;정재홍;임광채;조은주
    • 대한방사선치료학회지
    • /
    • 제21권1호
    • /
    • pp.1-7
    • /
    • 2009
  • 목 적: 로봇 사이버나이프에서 환자의 움직임에 의한 기준점의 위치변화 오차가 위치인식시스템(target location system, TLS) 을 통하여 targeting error값이 정확히 보정(correction)되는지 평가하고자 한다. 대상 및 방법: 본 실험은 targeting의 정확성을 분석하기 위해 head and neck팬텀에 Gafchromic 필름(MD-55)을 삽입한 후, 사이버나이프(CyberKnife Robotic Radiosurgery System G4, Accuray, US)의 6 MV X선을 조사하였다. 필름 분석은 Accuray사에서 제공하는 End to End (E2E) 프로그램을 이용하였다. 기준점의 위치에서 x, y, z방향으로 $0{\pm}0.2\;mm$, roll, pitch, yaw방향으로 $0{\pm}0.2^{\circ}$ 이내로 유지하여 12회 조사한 대조군과 인위적으로 움직임을 주어 실험을 시행한 6회의 실험군의 targeting 오차를 구하고, 대조군과 실험군의 평균값에 대한 유의성을 t-검정을 통해 분석하였다. 또한, gamma-index method (dose difference: 3%)를 통해 2차원적 선량분포의 일치성을 distance to agreement (DTA)를 각각 1 mm, 1.5 mm, 2 mm로 달리하여 정량화하고, 비교 분석하였다. 결 과: E2E test 시행 결과, 기준 필름의 targeting 평균오차 0.405 mm, 표준편차 0.069 mm, 실험 필름의 평균오차 0.413 mm, 표준편차 0.121 mm으로 나왔으며, t-검정 결과 유의확률 P=0.836 (신뢰구간 95%)으로 두 집단에서 유의한 차이를 볼 수 없었다. 또한, DTA를 각각 1 mm, 1.5 mm, 2 mm로 선량분포의 일치성을 비교한 결과 기준필름 3,314개 위치에서 axial필름 평균은 각각 95.04%, 97.56%, 98.13%, sagittal필름 평균은 각각 95.47%, 97.68%, 98.47% 일치하였다. 실험필름과 비교한 결과 3,323개 위치에서 axial필름 평균은 각각 96.38%, 97.57%, 98.04%, sagittal필름 평균은 각각 95.50%, 97.87%, 98.36% 일치하는 것을 확인할 수 있었다. 결 론: 로봇 사이버나이프는 치료 시 환자의 움직임에 의해 발생하는 기준점의 위치변화 오차를 실시간 추적하여 보정하며, targeting 오차를 1 mm 이내, 선량분포는 95% 이상 일치하는 정확성을 확인할 수 있었다.

  • PDF